Literature DB >> 16855618

Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways.

S G Sumner-Jones1, L A Davies, A Varathalingam, D R Gill, S C Hyde.   

Abstract

Recombinant adeno-associated virus vectors based on serotype 2 (rAAV2) have been used to deliver transgenes to the airways in a variety of pre-clinical and clinical studies. Gene transfer in these studies has been severely restricted by the basolateral localization of rAAV2 receptors. Here, we studied vectors constructed from the AAV5 genome and capsid, which utilize N-linked sialic acid-containing receptors found on the apical surface of airway epithelial cells. We investigated gene transfer efficacy and duration of transgene expression following delivery of rAAV5/5 vectors to the mouse respiratory tract. Robust, dose-dependent transgene expression was observed in the epithelium lining the nose for at least 32 weeks, and for at least 52 weeks in the lung. Importantly, in the lung, transgene expression mediated by rAAV5/5 was 40-fold greater than by rAAV2/2 vectors. A distinct cellular preference for rAAV5/5-mediated transduction was observed, with transgene expression being predominantly restricted to sustentacular cells of the olfactory epithelium in the nose and alveolar type II cells in the lung. Administration of rAAV5/5 vectors to both the nose and lungs led to the rapid development of rAAV5/5-neutralizing antibodies, suggesting that repeated administration may be severely hampered by host immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16855618     DOI: 10.1038/sj.gt.3302815

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  13 in total

1.  Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaques.

Authors:  Karen Nieto; Christiane Stahl-Hennig; Barbara Leuchs; Martin Müller; Lutz Gissmann; Jürgen A Kleinschmidt
Journal:  Hum Gene Ther       Date:  2012-04-18       Impact factor: 5.695

2.  Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.

Authors:  Anna R Kwilas; Mark A Yednak; Liqun Zhang; Rachael Liesman; Peter L Collins; Raymond J Pickles; Mark E Peeples
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

3.  Immunological ignorance allows long-term gene expression after perinatal recombinant adeno-associated virus-mediated gene transfer to murine airways.

Authors:  Marianne S Carlon; Dragana Vidović; James Dooley; Marina Mori da Cunha; Michael Maris; Youlia Lampi; Jaan Toelen; Chris Van den Haute; Veerle Baekelandt; Jan Deprest; Erik Verbeken; Adrian Liston; Rik Gijsbers; Zeger Debyser
Journal:  Hum Gene Ther       Date:  2014-03-26       Impact factor: 5.695

4.  Lack of repeat transduction by recombinant adeno-associated virus type 5/5 vectors in the mouse airway.

Authors:  Stephanie G Sumner-Jones; Deborah R Gill; Stephen C Hyde
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

5.  Cationic lipid formulations alter the in vivo tropism of AAV2/9 vector in lung.

Authors:  David E Fein; Maria P Limberis; Sean F Maloney; Jack M Heath; James M Wilson; Scott L Diamond
Journal:  Mol Ther       Date:  2009-07-28       Impact factor: 11.454

6.  Biochemical correction of short-chain acyl-coenzyme A dehydrogenase deficiency after portal vein injection of rAAV8-SCAD.

Authors:  Stuart G Beattie; Eric Goetzman; Thomas Conlon; Sean Germain; Glenn Walter; Martha Campbell-Thompson; Dietrich Matern; Jerry Vockley; Terence R Flotte
Journal:  Hum Gene Ther       Date:  2008-06       Impact factor: 5.695

7.  Vector serotype screening for use in ovine perinatal lung gene therapy.

Authors:  Lauren E McClain; Marcus G Davey; Phillip W Zoltick; Maria P Limberis; Alan W Flake; William H Peranteau
Journal:  J Pediatr Surg       Date:  2016-03-03       Impact factor: 2.545

8.  Sites in the AAV5 capsid tolerant to deletions and tandem duplications.

Authors:  Kaoru Hida; Sang Y Won; Giovanni Di Pasquale; Justin Hanes; John A Chiorini; Marc Ostermeier
Journal:  Arch Biochem Biophys       Date:  2010-01-25       Impact factor: 4.013

9.  Sustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity/type 2 diabetes.

Authors:  Giovanni Di Pasquale; Ilaria Dicembrini; Laura Raimondi; Claudio Pagano; Josephine M Egan; Andrea Cozzi; Lorenzo Cinci; Andrea Loreto; Maria E Manni; Silvia Berretti; Annamaria Morelli; Changyu Zheng; Drew G Michael; Mario Maggi; Roberto Vettor; John A Chiorini; Edoardo Mannucci; Carlo M Rotella
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

10.  Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.

Authors:  Uta Griesenbach; Makoto Inoue; Cuixiang Meng; Raymond Farley; Mario Chan; Nikki K Newman; Andrea Brum; Jun You; Angela Kerton; Amelia Shoemark; A Christopher Boyd; Jane C Davies; Tracy E Higgins; Deborah R Gill; Stephen C Hyde; J Alastair Innes; David J Porteous; Mamoru Hasegawa; Eric W F W Alton
Journal:  Am J Respir Crit Care Med       Date:  2012-09-06       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.